Patents by Inventor Christophe Sirac

Christophe Sirac has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC PROTEIN IN THE TREATMENT OF AMYLOIDOSIS
    Publication number: 20220356219
    Abstract: The present invention relates to a chimeric protein comprising at least one human amyloid P component and at least one fragment of an Fc region of a human antibody, the human amyloid P component and the fragment of an Fc region with which it is associated being bound to each other by means of a hinge region.
    Type: Application
    Filed: April 26, 2022
    Publication date: November 10, 2022
    Inventors: Christophe DE ROMEUF, Christophe SIRAC, Jean-Claude BROUET
  • Chimeric protein in the treatment of amyloidosis
    Patent number: 11345730
    Abstract: The present invention relates to a chimeric protein comprising at least one human amyloid P component and at least one fragment of an Fc region of a human antibody, the human amyloid P component and the fragment of an Fc region with which it is associated being bound to each other by means of a hinge region.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: May 31, 2022
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITÉ DE LIMOGES
    Inventors: Christophe de Romeuf, Christophe Sirac, Jean-Claude Brouet
  • Chimeric Protein in the Treatment of Amyloidosis
    Publication number: 20180298071
    Abstract: The present invention relates to a chimeric protein comprising at least one human amyloid P component and at least one fragment of an Fc region of a human antibody, the human amyloid P component and the fragment of an Fc region with which it is associated being bound to each other by means of a hinge region.
    Type: Application
    Filed: May 11, 2018
    Publication date: October 18, 2018
    Applicant: Laboratoire Francais du Fractionnement et des Biotechnologies
    Inventors: Christophe DE ROMEUF, Christophe Sirac
  • CHIMERIC PROTEIN IN THE TREATMENT OF AMYLOIDOSIS
    Publication number: 20160264637
    Abstract: The present invention relates to a chimeric protein comprising at least one human amyloid P component and at least one fragment of an Fc region of a human antibody, the human amyloid P component and the fragment of an Fc region with which it is associated being bound to each other by means of a hinge region.
    Type: Application
    Filed: October 31, 2014
    Publication date: September 15, 2016
    Applicants: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIO- TECHNOLOGIES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE LIMOGES
    Inventors: Christophe DE ROMEUF, Christophe SIRAC
  • Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications thereof
    Patent number: 8629317
    Abstract: The invention relates to a non-human transgenic mammal with an IgH locus modified by replacement of the switching sequence S? with all or part of a transgene comprising the gene C? of a class A human immunoglobulin, including at least the exon, coding for the CH3 domain and the membrane exon and the applications of the above for the production of humanized class IgA antibodies.
    Type: Grant
    Filed: October 21, 2004
    Date of Patent: January 14, 2014
    Assignees: Centre National de la Recherche Scientifique, Universite de Limoges
    Inventors: Michel Cogne, Christophe Sirac, Micael Bardel, Catherine Decourt, Caroline Le Morvan
  • Non-Human Transgenic Mammal for the Constant Region of the Class a Human Immunoglobulin Heavy Chain and Applications Thereof
    Publication number: 20070248601
    Abstract: The invention relates to a non-human transgenic mammal with an IgH locus modified by replacement of the switching sequence S?, with all or part of a transgene comprising the gene C? of a class A human immunoglobulin, including at least the exon, coding for the CH3 domain and the membrane exon and the applications of the above for the production of humanized class IgA antibodies.
    Type: Application
    Filed: October 21, 2004
    Publication date: October 25, 2007
    Applicants: Centre National De La Recherche Scientifique, Universite De Limoges
    Inventors: Michel Cogne, Christophe Sirac, Micael Bardel, Catherine Decourt, Caroline Le Morvan